Publications by authors named "Christopher G De Vry"
Page 1 of 1
Synopsis of recent research by authors named "Christopher G De Vry"
- Christopher G De Vry's research primarily focuses on the development and application of non-viral therapeutic strategies, particularly using oligonucleotides and immunomodulatory peptides, to manage inflammatory and autoimmune diseases such as inflammatory bowel disease and atopic dermatitis.
- His studies have demonstrated that the NF-kappaB decoy oligonucleotide can effectively suppress inflammation and restore tissue homeostasis in models of inflammatory bowel disease and atopic dermatitis, reducing reliance on corticosteroids.
- De Vry's novel immunomodulatory peptide, RDP58, has shown promising results in various experimental models by reducing pro-inflammatory cytokines involved in diseases like multiple sclerosis and dermatitis, indicating its potential for therapeutic use in managing autoimmune conditions.
